XKRX002070
Market cap18mUSD
Dec 26, Last price
908.00KRW
1D
1.79%
1Q
1.11%
Jan 2017
-79.48%
Name
Vivien Corp
Chart & Performance
Profile
Vivien Corporation operates in the lingerie market in South Korea. It sells its products under the VIVIEN, BBM, Maternity, GENTOFF, SUVIVIEN, DELOR, Rosebud, and PANDORA brands through a network of department stores and Vivian stores. The company was formerly known as Namyeung Vivien Corporation and changed its name to Vivien Corporation in August 2020. The company is based in Seoul, South Korea. As of January 21, 2020, Vivien Corporation operates as a subsidiary of KANGLIM Co., Ltd.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 217,298,021 1.99% | 213,052,157 13.41% | 187,863,421 2.49% | |||||||
Cost of revenue | 190,441,329 | 286,444,892 | 167,006,429 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 26,856,692 | (73,392,736) | 20,856,993 | |||||||
NOPBT Margin | 12.36% | 11.10% | ||||||||
Operating Taxes | (709,029) | (6,215,159) | 1,280,589 | |||||||
Tax Rate | 6.14% | |||||||||
NOPAT | 27,565,721 | (67,177,576) | 19,576,404 | |||||||
Net income | (7,784,352) -0.01% | (7,785,315) 155.51% | (3,046,945) -94.13% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 400,000 | 2,934,713 | ||||||||
BB yield | -1.06% | -3.52% | ||||||||
Debt | ||||||||||
Debt current | 75,128,073 | 73,592,480 | 3,438,277 | |||||||
Long-term debt | 8,175,815 | 11,305,165 | 72,726,493 | |||||||
Deferred revenue | 73,429 | 61,391 | ||||||||
Other long-term liabilities | 481,866 | 1,049,805 | 1,660,099 | |||||||
Net debt | 13,908,031 | 39,980,289 | 28,503,715 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,289,600 | (1,578,040) | (3,339,996) | |||||||
CAPEX | (1,171,097) | (842,865) | (1,811,594) | |||||||
Cash from investing activities | 1,107,409 | (9,093,227) | (9,198,172) | |||||||
Cash from financing activities | (1,383,890) | 8,933,845 | 5,866,537 | |||||||
FCF | 27,901,514 | (66,836,261) | 15,920,770 | |||||||
Balance | ||||||||||
Cash | 14,280,162 | 18,849,152 | 17,879,681 | |||||||
Long term investments | 55,115,695 | 26,068,204 | 29,781,374 | |||||||
Excess cash | 58,530,956 | 34,264,748 | 38,267,884 | |||||||
Stockholders' equity | 28,450,208 | 61,418,463 | 70,016,946 | |||||||
Invested Capital | 138,703,518 | 141,724,313 | 135,518,271 | |||||||
ROIC | 19.66% | 14.19% | ||||||||
ROCE | 16.07% | 12.00% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 29,794 | 29,794 | 28,120 | |||||||
Price | 1,252.00 -1.42% | 1,270.00 -57.17% | 2,965.00 -21.56% | |||||||
Market cap | 37,302,075 -1.42% | 37,838,367 -54.62% | 83,374,403 34.52% | |||||||
EV | 51,367,721 | 78,092,900 | 111,878,119 | |||||||
EBITDA | 30,020,482 | (70,198,090) | 24,033,249 | |||||||
EV/EBITDA | 1.71 | 4.66 | ||||||||
Interest | 5,972,159 | 19,971,740 | 3,190,811 | |||||||
Interest/NOPBT | 22.24% | 15.30% |